New clues to link between psoriasis and diabetes

| Melissa Leavitt

New findings may help explain why people with psoriasis are at risk for developing type 2 diabetes.

According to the results of a study published earlier this month in the Journal of the American Academy of Dermatology, one reason could be that psoriasis patients have more insulin resistance than people without the disease.

Insulin resistance is a risk factor for type 2 diabetes, the researchers noted. According to the American Diabetes Association, people who are insulin resistant require higher levels of insulin to properly absorb glucose. This condition, which is also known as low insulin sensitivity, leads to higher blood glucose levels.

Diabetes is a well-known comorbidity of psoriatic disease. Previous research has shown that people with severe psoriasis could be as much as 46 percent more likely to develop type 2 diabetes than people without psoriasis.

The study involved 16 people with moderate to severe psoriasis and 16 healthy controls, none of whom had diabetes, prediabetes or immediate family with diabetes. To test the insulin resistance of study participants, researchers administered a blood test called a hyperinsulinemic euglycemic clamp, described in the study as the “gold standard” for assessing insulin sensitivity.

People with psoriasis had significantly lower insulin sensitivity than people without psoriasis, the researchers reported, meaning that psoriasis patients were more insulin resistant. These findings suggest that psoriasis may be a prediabetic condition, the researchers added.

Previous studies have also identified insulin resistance in people with psoriasis, although only one has used the hyperinsulinemic euglycemic clamp method, according to the researchers.

The presence of insulin resistance in people with psoriasis could be because type 2 diabetes and psoriasis may have similar genetic risk factors, the study noted. Another possible explanation offered by the researchers is that people with either of these diseases have increased levels of cytokines, or proteins that can lead to inflammation.

Further research is needed to confirm these findings in a larger group of patients, and to learn more about the physiological mechanisms leading to insulin resistance in psoriasis patients, the researchers conclude.

Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

The 2019 Cure Symposium offered plenty of reasons to be optimistic about the...
NPF Researcher Charlotte Read
In this Q&A, 2018 NPF Psoriatic Disease Research Fellowship recipient...
NPF launches an ambitious strategic plan to guide all our functions and...
Carol Selby
In her role as a research ambassador for NPF, Carol Selby provides an important...
Close-up Lena Oslund standing by pool
Lena Oslund is young, confident and living life the way she wants to live it.
Dr. Ronald Prussick
A chance meeting with an inspiring mentor channels a promising physician into a...
Kumar Family
The Kumar family from Southern California discover that they are not alone and...
doctor facing patient across desk
The Corrona Psoriasis Registry will give health care providers the data needed...
Charlotte Community
Researcher Charlotte Hurabielle-Claverie, M.D., finds joy in unraveling the...